Report of the radionuclides in nephrourology committee for evaluation of transplanted kidney (review of techniques)

https://doi.org/10.1016/S0001-2998(99)80007-5Get rights and content

Comprehensive evaluation of renal transplants has been important in differential diagnosis of medical and surgical complications in the early post-transplantation period and in the long-term follow-up. If performed well, it yields excellent functional and good anatomic information about the graft that can be effectively used in the patient. That includes selection of patients for biopsy and for various drug regimens. This is true especially in patients with anuric acute tubular necrosis (ATN) and in patients with developing chronic rejection. Improving indices of renal function (effective renal plasma flow, uptake of tubular tracers) can indicate resolution of tubular injury (ATN) while there is still no improvement in plasma creatinine. In patients with chronic rejection, plasma creatinine increases only after approximately 30% of renal function is lost due to graft fibrosis. Early recognition of this condition could permit treatment and delay of retransplantation. The protocol recommended at the Copenhagen meeting includes a flow study, scintigram of the kidneys, prevoid and postvoid bladder image, injection site image (quality control), time/activity curves of the graft and bladder, and quantitative data of perfusion, function, and tracer transit. The flow study obtained during the initial transit of the bolus through the graft could be performed either with 99mTc mercaptoacetyltriglycine, or 99mTc diethylenetriamine-pentaacetate (DTPA). Quantitative analysis of perfusion facilitates interpretation of the study during the early post-transplantation period. ATN, common in cadaver transplants, typically shows adequate perfusion. The function phase should include images and time/activity curves. Images alone are insufficient. Quantitative data such as clearance or other indices of function and indices of tracer transit are essential for correct interpretation of the results. Normal images and normal graft function reliably exclude clinically important complications. A single scintigram demonstrating prolonged tracer transit with decreased function cannot separate acute rejection and ATN. On serial studies, decline in function and poor perfusion are indicative of acute rejection. A normally appearing scintigram without cortical retention, but with low function, is consistent with chronic rejection. Pharmacological intervention to exclude obstruction (diuretic renogram) or hemodynamically significant renal artery stenosis (angiotensin converting enzyme challenge) should be used whenever indicated.

References (43)

  • RaoKV et al.

    Acute graft rejection in the late survivors of renal transplantation

    Transplant

    (1989)
  • KirkpatrickCH

    Transplantation immunology

    JAMA

    (1987)
  • OeiHY

    The significance of renoscintigraphy for renal transplantation

  • OeiHY et al.

    Diagnosis of acute rejection in renal allograft by determination of tubular transit index

  • HilsonAJW et al.

    Dynamic renal transplant imaging with Tc-99m DTPA (Sn) supplemented by a transplant perfusion index in the management of renal transplants

    J Nucl Med

    (1978)
  • KirchnerPT et al.

    Clinical application of the kidney and aortic blood flow index (K/A ratio)

    Contrib Nephrol

    (1978)
  • BubeckB

    Technetium-99m-MAG3 fuer die nuklear-medizinische Nierenfunktionsdiagnostik. Pharmakokinetik und klinische Anwendung in Vergleich mit radiojodierter Hippursaeure

    (1993)
  • AshJ et al.

    Quantitative assessment of blood flow in recipients of renal transplants

    J Nucl Med

    (1990)
  • PetersAM et al.

    Noninvasive measurement of blood flow and extraction fraction

    Nucl Med Comun

    (1987)
  • RutlandMD

    A comprehensive analysis of renal DTPA studies. II. Renal transplant evaluation

    Nucl Med Commun

    (1985)
  • ChaiwatanaratT et al.

    Renal vascular transit time: a new renal blood flow parameter in evaluation of post-renal transplant complications

    J Nucl Med

    (1994)
  • Cited by (69)

    • Gamma camera imaging of renal transplant

      2022, Nuclear Medicine and Molecular Imaging: Volume 1-4
    • Imaging in Renal Transplants: An Update

      2021, Seminars in Nuclear Medicine
    • Peri- and Postsurgical Evaluations of Renal Transplant

      2017, Seminars in Nuclear Medicine
      Citation Excerpt :

      Radionuclide imaging is a modality capable of assessing graft function, not only qualitatively but also quantitatively. Methodology of renal imaging for the assessment of renal transplant function has not changed much over the years.14,15 Routinely, renal scintigraphy consists of three phases, that is, renal perfusion, uptake function of the radiopharmaceutical, and drainage of the tracer from the collecting system.

    • Renal Transplant Evaluation

      2016, Diagnostic Imaging: Nuclear Medicine
    • Transplanted kidney function evaluation

      2014, Seminars in Nuclear Medicine
      Citation Excerpt :

      Despite the distinct histologic presentations, previous studies have shown that grades I and II AR seem to have similar clinical behavior, rejection response rates, and graft survival after reversal of the attack.39 In the report of radionuclides for the evaluation of the transplanted kidney, it was stated that cell-mediated AR and ATN have similar scan appearances with MAG3, and that these entities can be separated by their time course and sequential perfusion and function changes, provided an early posttransplantation study is available.40 Accordingly, on serial studies, the graft function declines in AR and improves in uncomplicated ATN.

    • Renal scintigraphy in the acute care setting

      2013, Seminars in Nuclear Medicine
    View all citing articles on Scopus
    View full text